Week In Review: Hengrui Launches US Subsidiary To Bring Novel Medicines To Global Markets
May 21, 2022 at 14:20 PM EDT
Hengrui Pharma launched a new company, Luzsana Biotechnology, which is devoted to making the most advanced medications available and affordable. Meanwhile, Sichuan Kelun Pharmaceutical out-licensed global rights for a molecule candidate to Merck.
